{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:23:48Z","timestamp":1770416628692,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T00:00:00Z","timestamp":1521849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["BIO2012-31251"],"award-info":[{"award-number":["BIO2012-31251"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00253-018-8930-8","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T23:35:06Z","timestamp":1521934506000},"page":"4477-4487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enhancement of HIV-1 VLP production using gene inhibition strategies"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6254-8034","authenticated-orcid":false,"given":"Javier","family":"Fuenmayor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rigau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"G\u00f2dia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,24]]},"reference":[{"key":"8930_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.nbt.2008.08.007","volume":"25","author":"G Backliwal","year":"2008","unstructured":"Backliwal G, Hildinger M, Chenuet S, DeJesus M, Wurm FM (2008a) Coexpression of acidic fibroblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cells. New Biotechnol 25:162\u2013166","journal-title":"New Biotechnol"},{"issue":"15","key":"8930_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn423","volume":"36","author":"G Backliwal","year":"2008","unstructured":"Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM (2008b) Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g\/l by transient transfection under serum-free conditions. Nucleic Acids Res 36(15):e96","journal-title":"Nucleic Acids Res"},{"key":"8930_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/bit.21882","volume":"101","author":"G Backliwal","year":"2008","unstructured":"Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM (2008c) Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng 101:182\u2013189","journal-title":"Biotechnol Bioeng"},{"key":"8930_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10529-006-9297-y","volume":"29","author":"L Baldi","year":"2007","unstructured":"Baldi L, Hacker DL, Adam M, Wurm FM (2007) Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett 29:677\u2013684","journal-title":"Biotechnol Lett"},{"key":"8930_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jbiotec.2013.05.001","volume":"166","author":"L Cervera","year":"2013","unstructured":"Cervera L, Guti\u00e9rrez-Granados S, Mart\u00ednez M, Blanco J, G\u00f2dia F, Segura MM (2013) Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium. J Biotechnol 166:152\u2013165","journal-title":"J Biotechnol"},{"key":"8930_CR6","doi-asserted-by":"publisher","first-page":"9935","DOI":"10.1007\/s00253-015-6842-4","volume":"99","author":"L Cervera","year":"2015","unstructured":"Cervera L, Fuenmayor J, Gonz\u00e1lez-Dom\u00ednguez I, Guti\u00e9rrez-Granados S, Segura MM, G\u00f2dia F (2015a) Selection and optimization of transfection enhancer additives for increased virus-like particle production in HEK293 suspension cell cultures. Appl Microbiol Biotechnol 99:9935\u20139949","journal-title":"Appl Microbiol Biotechnol"},{"key":"8930_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/bit.25503","volume":"112","author":"L Cervera","year":"2015","unstructured":"Cervera L, Guti\u00e9rrez-Granados S, Berrow NS, Segura MM, G\u00f2dia F (2015b) Extended gene expression by medium exchange and repeated transient transfection for recombinant protein production enhancement. Biotechnol Bioeng 112:934\u2013946","journal-title":"Biotechnol Bioeng"},{"key":"8930_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0024-3205(88)90517-6","volume":"43","author":"OH Choi","year":"1988","unstructured":"Choi OH, Shamim MT, Daly JW, Padgett L (1988) Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci 43:387\u2013398","journal-title":"Life Sci"},{"key":"8930_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/hum.2010.068","volume":"22","author":"BL Ellis","year":"2011","unstructured":"Ellis BL, Potts PR, Porteus MH (2011) Creating higher titer lentivirus with caffeine. Hum Gene Ther 22:93\u2013100","journal-title":"Hum Gene Ther"},{"key":"8930_CR10","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/bit.25626","volume":"112","author":"S Fischer","year":"2015","unstructured":"Fischer S, Paul AJ, Wagner A, Mathias S (2015) miR-2861 as novel HDAC5 inhibitor in CHO cells enhances productivity while maintaining product quality. Biotechnol Bioeng 112:2142\u20132153","journal-title":"Biotechnol Bioeng"},{"key":"8930_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00253-017-8605-x","volume":"102","author":"J Fuenmayor","year":"2017","unstructured":"Fuenmayor J, Cervera L, Guti\u00e9rrez-Granados S, Godia F (2017a) Transient gene expression optimization and expression vector comparison to improve HIV-1 VLP production in HEK293 cell lines. Appl Microbiol Biotechnol 102:165\u2013174","journal-title":"Appl Microbiol Biotechnol"},{"key":"8930_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","volume":"39","author":"J Fuenmayor","year":"2017","unstructured":"Fuenmayor J, G\u00f2dia F, Cervera L (2017b) Production of virus-like particles for vaccines. New Biotechnol 39:174\u2013180","journal-title":"New Biotechnol"},{"key":"8930_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jviromet.2013.05.010","volume":"193","author":"S Guti\u00e9rrez-Granados","year":"2013","unstructured":"Guti\u00e9rrez-Granados S, Cervera L, G\u00f2dia F, Carrillo J, Segura MM (2013) Development and validation of a quantitation assay for fluorescently tagged HIV-1 virus-like particles. J Virol Methods 193:85\u201395","journal-title":"J Virol Methods"},{"key":"8930_CR14","doi-asserted-by":"publisher","first-page":"8670","DOI":"10.1128\/JVI.74.18.8670-8679.2000","volume":"74","author":"L Hermida-Matsumoto","year":"2000","unstructured":"Hermida-Matsumoto L, Resh MD (2000) Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol 74:8670\u20138679","journal-title":"J Virol"},{"key":"8930_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0959-437X(00)00174-X","volume":"11","author":"S Khochbin","year":"2001","unstructured":"Khochbin S, Verdel A, Lemercier C, Seigneurin-Berny D (2001) Functional significance of histone deacetylase diversity. Curr Opin Genet Dev 11:162\u2013166","journal-title":"Curr Opin Genet Dev"},{"key":"8930_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12033-008-9051-x","volume":"39","author":"C Liu","year":"2008","unstructured":"Liu C, Dalby B, Chen W, Kilzer JM, Chiou HC (2008) Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells. Mol Biotechnol 39:141\u2013153","journal-title":"Mol Biotechnol"},{"key":"8930_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ncb2895","volume":"16","author":"SW Lowe","year":"2014","unstructured":"Lowe SW (2014) Stable RNA interference rules for silencing. Nat Cell Biol 16:10\u201318","journal-title":"Nat Cell Biol"},{"key":"8930_CR18","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JVI.68.6.4067-4071.1994","volume":"68","author":"T Middleton","year":"1994","unstructured":"Middleton T, Sugden B (1994) Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol 68:4067\u20134071","journal-title":"J Virol"},{"key":"8930_CR19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Roldao","year":"2010","unstructured":"Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9:1149\u20131176","journal-title":"Expert Rev Vaccines"},{"key":"8930_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/sj.cdd.4401581","volume":"12","author":"S Roy","year":"2005","unstructured":"Roy S, Packman K, Jeffrey R, Tenniswood M (2005) Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells. Cell Death Differ 12:482\u2013491","journal-title":"Cell Death Differ"},{"key":"8930_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00340712","volume":"16","author":"RH Schiestl","year":"1989","unstructured":"Schiestl RH, Gietz RD (1989) High efficiency transformation of intact yeast cells using single-stranded nucleic acids as carrier. Curr Genet 16:339\u2013346","journal-title":"Curr Genet"},{"key":"8930_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1021\/bp00003a013","volume":"6","author":"E Suzuki","year":"1990","unstructured":"Suzuki E, Ollis DF (1990) Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured model. Biotechnol Prog 6:231\u2013236","journal-title":"Biotechnol Prog"},{"key":"8930_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/bit.20265","volume":"88","author":"AS Tait","year":"2004","unstructured":"Tait AS, Brown CJ, Galbraith DJ, Hines MJ, Hoare M, Birch JR, James DC (2004) Transient production of recombinant proteins by Chinese hamster ovary cells using polyethyleneimine\/DNA complexes in combination with microtubule disrupting anti-mitotic agents. Biotechnol Bioeng 88:707\u2013721","journal-title":"Biotechnol Bioeng"},{"key":"8930_CR24","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/nar\/27.7.1674","volume":"27","author":"R Wade-Martins","year":"1999","unstructured":"Wade-Martins R, Frampton J, James MR (1999) Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. Nucleic Acids Res 27:1674\u20131682","journal-title":"Nucleic Acids Res"},{"key":"8930_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/bit.22265","volume":"103","author":"J Ye","year":"2009","unstructured":"Ye J, Kober V, Tellers M, Naji Z, Salmon P, Markusen JF (2009) High-level protein expression in scalable CHO transient transfection. Biotechnol Bioeng 103:542\u2013551","journal-title":"Biotechnol Bioeng"},{"key":"8930_CR26","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.biotechadv.2011.08.022","volume":"30","author":"J Zhu","year":"2012","unstructured":"Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30:1158\u20131170","journal-title":"Biotechnol Adv"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-018-8930-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-018-8930-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-018-8930-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T04:13:36Z","timestamp":1604031216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-018-8930-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,24]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["8930"],"URL":"https:\/\/doi.org\/10.1007\/s00253-018-8930-8","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,24]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}